View 1: Corneal scraping and combination antibiotic therapy is indicated

British Journal of Ophthalmology

Volumn 87, Issue 9, 2003, Pages 1167-1169

  Mills, R ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CEFAZOLIN; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; FLUCONAZOLE; GENTAMICIN; ITRACONAZOLE; NATAMYCIN; NORFLOXACIN; OFLOXACIN; PENICILLIN DERIVATIVE; POLY(HEXAMETHYLENEBIGUANIDE); PROPAMIDINE ISETHIONATE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN; ANTIINFECTIVE AGENT;

ACANTHAMOEBA; ANIMAL CELL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; BACTERIUM CULTURE; CANDIDA; CANDIDIASIS; CORNEA CELL; CORNEA DISEASE; CORNEA PERFORATION; DRUG CYTOTOXICITY; EYE INFECTION; EYE TOXICITY; HUMAN; KERATITIS; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS; RABBIT; REVIEW; SIDE EFFECT; STAPHYLOCOCCUS; STREPTOCOCCUS PNEUMONIAE; ACANTHAMOEBA KERATITIS; BACTERIAL EYE INFECTION; DRUG COMBINATION; FUNGAL EYE INFECTION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; NOTE; ARTICLE; CONTACT LENS;

ACANTHAMOEBA KERATITIS; ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; EYE INFECTIONS; EYE INFECTIONS, BACTERIAL; EYE INFECTIONS, FUNGAL; HUMANS; KERATITIS; MICROBIOLOGICAL TECHNIQUES; CONTACT LENSES;

EID: 0141976277     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.87.9.1167     Document Type: Review

References (25)

1. Jones DB, Decision making in the management of microbial keratitis. Ophthalmology 1981;88:814-20.
2. Davis SD, Sarff LD, Hyndiuk RA. Antibiotic therapy of experimental Pseudomonas keratitis in guinea pigs. Arch Ophthalmol 1977;95:1638-43.
3. Davis SD, Sarff LD, Hyndiuk RA. Topical tobramycin therapy of experimental Pseudomonas keratitis. An evaluation of some factors that potentially enhance efficacy. Arch Ophthalmol 1978;96:123-5.
4. Kuperfman A, Leibowitz HM. Topical antibiotic therapy of Pseudomonas aeruginosa keratitis. Arch Ophthalmol 1979;97:1699-702.
5. Jones DB. Strategy for the initial management of suspected microbial keratitis. In: symposium on medical and surgical diseases of the cornea. Transactions of the New Orleans Academy of Ophthalmology. St Louis: CV Mosby, 1980:86-119.
6. Gangopadhyay N, Daniell M, Weih L, et al. Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers. Br J Ophthalmol 2000;84:378-84.
7. Leibowitz H. Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis. Am J Ophthalmol 1991;112:34S-47S.
8. Wilhelmus KR, Hyndiuk R, Caldwell D, et al. 0.3% Ciprofloxacin ophthalmic ointment in the treatment of bacterial keratitis. Arch Ophthalmol 1993;111:1210-18.
9. O'Brien TP, Maguire MG, Fink NE, et al. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Arch Ophthalmol 1995;113:1257-65.
10. Hyndiuk RA, Eiferman RA, Caldwell DR et al. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ophthalmology 1996;103:1854-63.
11. Ofloxacin Study Group. Ofloxacin monotherapy for the primary treatment of microbial keratitis. A double-masked, randomized, controlled trial with conventional dual therapy. Ophthalmology 1997;104:1902-9.
12. Allan BD, Dart JK. Strategies for the management of microbial keratitis. Br J Ophthalmol 1995;79:777-86.
13. Goldstein M, Kowalski M, Gordon G. Emerging fluoroquinolone resistance in bacterial keratitis. Ophthalmology 1999;106:1313-18.
14. Garg P, Sharma S, Rao G. Ciprofloxacin-resistant Pseudomonas keratitis. Ophthalmology 1999;106:1319-23.
15. Guzek JP, Cline DJ, Row PK, et al. Rabbit Streptococcus pneumoniae keratitis model and topical therapy. Invest Ophthalmol Vis Sci 1998;39:2012-17.
16. Bower KS, Kowalski RP, Gordon YJ. Fluoroquinolones in the treatment of bacterial keratitis. Am J Ophthalmol 1996;121:712-15.
17. Jones DB. Emerging antibiotic resistance: real and relative. Arch Ophthalmol 1996;114:91-2.
18. Mallari P, McCarty D, Daniell M, et al. Increased incidence of corneal perforation after topical fluoroquinolone treatment for microbial keratitis. Am J Ophthalmol 2001;131:131-3.
19. Seitz B, Hayashi S, Wee W, et al. In vitro effects of aminoglycosides and fluoroquinolones on keratocytes. Invest Ophthalmol Vis Sci 1996;37:656-65.
20. McLeod S, DeBacker C, Viana M. Differential care of corneal ulcers in the community based on apparent severity. Ophthalmology 1995;103:479-84.
21. O'Day DM. Fungal keratitis. In: Fraunfelder FT, Roy FH, eds. Current ocular therapy. Philadelphia: WB Saunders, 2000:360-1.
22. Panda A, Sharma N, Angra S. Topical fluconazole therapy of Candida keratitis. Cornea 1996;15:373-5.
23. Thakar M. Oral fluconazole therapy for keratomycosis. Acta Ophthalmol 1994;72:765-7.
24. Koltz S, Zahid M, Bartholomew W, et al. Candida albicans keratitis treated successfully with itraconazole. Cornea 1996;15:102-4.
25. Duguid IG, Dart JK, Morlet N, et al. Outcome of Acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine. Ophthalmology 1997;104:1587-92.